246 related articles for article (PubMed ID: 18184111)
1. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases.
San José G; Fortuño A; Beloqui O; Díez J; Zalba G
Clin Sci (Lond); 2008 Feb; 114(3):173-82. PubMed ID: 18184111
[TBL] [Abstract][Full Text] [Related]
2. CYBA gene variants as biomarkers for coronary artery disease.
Moreno MU; Zalba G
Drug News Perspect; 2010 Jun; 23(5):316-24. PubMed ID: 20603655
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
4. NADPH oxidase and endothelial cell function.
Ray R; Shah AM
Clin Sci (Lond); 2005 Sep; 109(3):217-26. PubMed ID: 16104842
[TBL] [Abstract][Full Text] [Related]
5. Endothelins and NADPH oxidases in the cardiovascular system.
Dammanahalli KJ; Sun Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):2-6. PubMed ID: 18047620
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidases in cardiovascular disease.
Brandes RP; Weissmann N; Schröder K
Free Radic Biol Med; 2010 Sep; 49(5):687-706. PubMed ID: 20444433
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and vascular remodelling.
Fortuño A; San José G; Moreno MU; Díez J; Zalba G
Exp Physiol; 2005 Jul; 90(4):457-62. PubMed ID: 15890797
[TBL] [Abstract][Full Text] [Related]
8. Impact of NAD(P)H oxidase p22 phox gene polymorphism on vascular aging in Korean centenarian and nonagenarian.
Kim KI; Na JE; Kang SY; Cho YS; Choi DJ; Kim CH; Kim HS; Oh BH; Choi YH; Kwon IS; Park SC
Int J Cardiol; 2007 Dec; 123(1):18-22. PubMed ID: 17307262
[TBL] [Abstract][Full Text] [Related]
9. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension.
Moreno MU; San José G; Fortuño A; Beloqui O; Díez J; Zalba G
J Hypertens; 2006 Jul; 24(7):1299-306. PubMed ID: 16794479
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension.
Zalba G; San José G; Moreno MU; Fortuño A; Díez J
Antioxid Redox Signal; 2005; 7(9-10):1327-36. PubMed ID: 16115038
[TBL] [Abstract][Full Text] [Related]
11. A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension.
Moreno MU; San José G; Fortuño A; Beloqui O; Redón J; Chaves FJ; Corella D; Díez J; Zalba G
J Hypertens; 2007 Aug; 25(8):1620-6. PubMed ID: 17620958
[TBL] [Abstract][Full Text] [Related]
12. Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation.
Bedard K; Attar H; Bonnefont J; Jaquet V; Borel C; Plastre O; Stasia MJ; Antonarakis SE; Krause KH
Hum Mutat; 2009 Jul; 30(7):1123-33. PubMed ID: 19388116
[TBL] [Abstract][Full Text] [Related]
13. Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors.
Selemidis S
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1395-401. PubMed ID: 18954334
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure.
Perianayagam MC; Liangos O; Kolyada AY; Wald R; MacKinnon RW; Li L; Rao M; Balakrishnan VS; Bonventre JV; Pereira BJ; Jaber BL
J Am Soc Nephrol; 2007 Jan; 18(1):255-63. PubMed ID: 17151330
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions.
Czesnikiewicz-Guzik M; Lorkowska B; Zapala J; Czajka M; Szuta M; Loster B; Guzik TJ; Korbut R
J Physiol Pharmacol; 2008 Mar; 59(1):139-52. PubMed ID: 18441394
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants.
Soccio M; Toniato E; Evangelista V; Carluccio M; De Caterina R
Eur J Clin Invest; 2005 May; 35(5):305-14. PubMed ID: 15860042
[TBL] [Abstract][Full Text] [Related]
17. The C242T polymorphism of the NAD(P)H oxidase p22phox subunit is associated with an enhanced risk for cerebrovascular disease at a young age.
Genius J; Grau AJ; Lichy C
Cerebrovasc Dis; 2008; 26(4):430-3. PubMed ID: 18799874
[TBL] [Abstract][Full Text] [Related]
18. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
Guzik TJ; Harrison DG
Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
[TBL] [Abstract][Full Text] [Related]
19. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.
Bedard K; Krause KH
Physiol Rev; 2007 Jan; 87(1):245-313. PubMed ID: 17237347
[TBL] [Abstract][Full Text] [Related]
20. Non-effect of p22-phox -930A/G polymorphism on end-organ damage in Brazilian hypertensive patients.
Sales ML; Ferreira MC; Leme CA; Velloso LA; Gallani MC; Colombo RC; Franchini KG; Nadruz W
J Hum Hypertens; 2007 Jun; 21(6):504-6. PubMed ID: 17314996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
